TY - JOUR
T1 - Viremia and neutralizing antibody response in infants with exanthem subitum
AU - Asano, Yoshizo
AU - Yoshikawa, Tetsushi
AU - Suga, Sadao
AU - Yazaki, Takehiko
AU - Hata, Tadayoshi
AU - Nagai, Takao
AU - Kajita, Yuji
AU - Ozaki, Takao
AU - Yoshida, Shigeru
PY - 1989/4
Y1 - 1989/4
N2 - Mononuclear cell-associated viremia caused by human herpesvirus type 6 was detected in 39 (66%) of 59 blood samples from 38 children with exanthem subitum between day 0 and day 7 of the disease. The rate of virus isolation from mononuclear cells was 100% (26/26) on days 0 to 2 (just before appearance of skin rash), 82% (9/11) on day 3,20% (2/10) on day 4,7% (2/12) on days 5 to 7, and 0% (0/37) on day 8 and thereafter. The cell-free virus was detected in blood in 10 (21%) of 47 blood samples during the same period. The antibody activity to the virus, evaluated by a newly developed neutralization assay, was first detected on day 3 of the disease with a positive rate of 18% (2/11). It became 60% (6/10) on day 4, 75% (9/12) on days 5 to 7, and 100% on day 8 and thereafter. Thus the disappearance of the virus from blood was associated with the induction of specific immunity to the virus.
AB - Mononuclear cell-associated viremia caused by human herpesvirus type 6 was detected in 39 (66%) of 59 blood samples from 38 children with exanthem subitum between day 0 and day 7 of the disease. The rate of virus isolation from mononuclear cells was 100% (26/26) on days 0 to 2 (just before appearance of skin rash), 82% (9/11) on day 3,20% (2/10) on day 4,7% (2/12) on days 5 to 7, and 0% (0/37) on day 8 and thereafter. The cell-free virus was detected in blood in 10 (21%) of 47 blood samples during the same period. The antibody activity to the virus, evaluated by a newly developed neutralization assay, was first detected on day 3 of the disease with a positive rate of 18% (2/11). It became 60% (6/10) on day 4, 75% (9/12) on days 5 to 7, and 100% on day 8 and thereafter. Thus the disappearance of the virus from blood was associated with the induction of specific immunity to the virus.
UR - http://www.scopus.com/inward/record.url?scp=0024573964&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024573964&partnerID=8YFLogxK
U2 - 10.1016/S0022-3476(89)80689-4
DO - 10.1016/S0022-3476(89)80689-4
M3 - Article
C2 - 2647944
AN - SCOPUS:0024573964
SN - 0022-3476
VL - 114
SP - 535
EP - 539
JO - The Journal of Pediatrics
JF - The Journal of Pediatrics
IS - 4 PART 1
ER -